Abrir app
Top 100 emisorasPodcastDeporte en directoEn tu zonaGéneros musicalesTemas de emisoras
PodcastsCienciasBiotechTV - News
Escucha gratis este podcast en la aplicación:
BiotechTV - News
radio.net
Sleep timer
Favoritos
Descarga gratuita en la App Store

BiotechTV - News

BiotechTV
CienciasCiencias de la vida
BiotechTV - News
Último episodio

393 episodios

  • BiotechTV - News

    Barclays Miami: MannKind CEO Michael Castagna shares an update on the company, including a recent $360M acquisition, and two regulatory reviews at FDA that have decision dates over the coming months

    11/03/2026 | 14 min
    He describes learnings from Afrezza's commercialization, why the company acquired scPharmaceuticals, an update on their partnership with United Therapeutics in PAH, and a key IPF asset that is in the pipeline.
  • BiotechTV - News

    Barclays Miami: Barclays' Senior Biotech Analyst Etzer Darout shares his take on biotech and discusses companies he covers that have been in the news

    11/03/2026 | 14 min
    He comments on Abivax, Corvus, Iovance, Legend, Terns, and more.
  • BiotechTV - News

    Barclays Miami: Zealand Pharma CEO Adam Steensberg makes the case for last week's amylin data

    11/03/2026 | 12 min
    He argues that investors are too focused on each percentage of weight loss and not focused enough on the tolerability of new options. He discusses the timeline for the phase 3 that will likely start later this year, and how it might look different than the phase 2 study that just read out.
  • BiotechTV - News

    Barclays Miami: Barclays' Head of Healthcare M&A shares his take on the current environment of dealmaking

    11/03/2026 | 5 min
    Maneet Singh says that pharma companies need to keep buying, and have the financial wherewithal to do it. He also gives thoughts on which areas within biotech could attract the most interest.
  • BiotechTV - News

    Reunion Neuroscience recently received Breakthrough Therapy Designation from FDA for its psychedelic based treatment for postpartum depression (PPD)

    11/03/2026 | 11 min
    CEO Greg Mayes describes the science behind luvesilocin, which is a prodrug of 4-OH-DiPT, a psilocybin-like compound, and discusses the company's plans for a phase 3 study. Plus, comments on two other indications the company is pursuing.

Más podcasts de Ciencias

Podcasts a la moda de Ciencias

Acerca de BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
Sitio web del podcast
CienciasCiencias de la vida

Escucha BiotechTV - News, Materia Oscura y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app
Abrir app

BiotechTV - News: Podcasts del grupo

Empresa
Información legal
Servicio
Aplicaciones
Redes sociales
Radio Colombia
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/13/2026 - 11:58:08 AM
Una empresa deMADSACK